Single-dose pharmacokinetics of oral fleroxacin in bacteremic patients.

Fleroxacin is a new broad-spectrum quinolone which can be given by the oral route. The present study was designed to assess the influence of bacteremia on the pharmacokinetics of a single oral dose of fleroxacin. Thirteen patients with proven bacteremia (one or more pairs of positive blood cultures,...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Schrenzel, J, Cerruti, F, Herrmann, M, Leemann, T, Weidekamm, E, Portmann, R, Hirschel, B, Lew, D P
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1994
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188189/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8092817/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.6.1219
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!